Screener
Ionis Pharmaceuticals IONS Interest Expense Related To Sale Of Future Royalties
Interest Expense Related To Sale Of Future Royalties at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:InterestExpenseRelatedToSaleOfFutureRoyalties.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Amortization of discount on investments, net | (9,533) | (12,978) |
| Amortization of debt issuance costs | 4,150 | 3,288 |
| Non-cash royalty revenue related to sale of royalties | (22,387) | (24,894) |
| Non-cash interest related to sale of future royalties | 34,538 | 37,165 |
| Stock-based compensation expense | 88,870 | 59,408 |
| Loss (gain) on investments, net | (12,401) | 20,471 |
| Non-cash losses related to other assets | 481 | 297 |
| Changes in operating assets and liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's interest expense related to sale of future royalties?
- Ionis Pharmaceuticals (IONS) reported interest expense related to sale of future royalties of $17.35M in Q2 2026.
- How has Ionis Pharmaceuticals's interest expense related to sale of future royalties changed year-over-year?
- Ionis Pharmaceuticals's interest expense related to sale of future royalties decreased by 6.2% year-over-year, from $18.5M to $17.35M.
- What does interest expense related to sale of future royalties mean?
- The interest expense associated with financing arrangements where the company sells the rights to future royalty streams in exchange for upfront cash. This represents the cost of capital for monetizing future revenue.
Ask your AI about Ionis Pharmaceuticals's interest expense related to sale of future royalties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude